Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS: ENZN · Delayed Price · USD
0.400
-0.047 (-10.49%)
Aug 9, 2022 12:43 PM - Market open
ENZN Market Cap
ENZN has a market cap or net worth of $29.69 million as of August 9, 2022. ENZN's market cap has increased by +37.02% in one year.
Market Cap
29.69M
Enterprise Value
-17.96M
1-Year Change
+37.02%
Ranking
n/a
Category
Nano-Cap
Stock Price
$0.400
Market Cap Chart
Since February 15, 1984, ENZN's market cap has increased from $11.72 million to $29.69 million, an increase of 153.28%. That is a compound annual growth rate of 2.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 9, 2022 | 29.69M | -10.50% |
| Aug 8, 2022 | 33.17M | - |
| Aug 5, 2022 | 33.17M | 8.74% |
| Aug 4, 2022 | 30.50M | - |
| Aug 3, 2022 | 30.50M | 28.56% |
| Aug 2, 2022 | 23.73M | -8.87% |
| Aug 1, 2022 | 26.03M | 4.72% |
| Jul 29, 2022 | 24.86M | -1.47% |
| Jul 28, 2022 | 25.23M | 5.92% |
| Jul 26, 2022 | 23.82M | 6.15% |
| Jul 25, 2022 | 22.44M | 3.88% |
| Jul 22, 2022 | 21.60M | -1.32% |
| Jul 21, 2022 | 21.89M | - |
| Jul 20, 2022 | 21.89M | -3.22% |
| Jul 19, 2022 | 22.62M | - |
| Jul 18, 2022 | 22.62M | -0.39% |
| Jul 15, 2022 | 22.71M | 3.73% |
| Jul 14, 2022 | 21.89M | 1.44% |
| Jul 13, 2022 | 21.58M | -2.38% |
| Jul 12, 2022 | 22.11M | -3.66% |
| Jul 11, 2022 | 22.95M | 0.07% |
| Jul 8, 2022 | 22.93M | - |
| Jul 7, 2022 | 22.93M | - |
| Jul 6, 2022 | 22.93M | -7.84% |
| Jul 5, 2022 | 24.88M | 3.17% |
View and export this data all the way back to 1983.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition
Related Stocks
| Company | Market Cap |
|---|---|
| Pharma-Bio Serv | 19.28M |
| Provectus Biopharmaceuticals | 23.07M |
| Rapid Therapeutic Science Laboratories | 15.26M |
| Elbit Imaging | 14.29M |
| Cell Source | 25.83M |
| CURE Pharmaceutical Holding | 23.75M |
| Odyssey Group International | 12.69M |